Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Current Taxes (2021 - 2023)

Atea Pharmaceuticals' Current Taxes history spans 3 years, with the latest figure at $23000.0 for Q2 2023.

  • Quarterly Current Taxes rose 53.33% to $23000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $23000.0 through Jun 2023, up 53.33% year-over-year, with the annual reading at $99000.0 for FY2022, 96.15% down from the prior year.
  • Current Taxes came in at $23000.0 for Q2 2023, down from $178000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $12.0 million in Q3 2021 to a low of $15000.0 in Q2 2022.
  • The 3-year median for Current Taxes is $708000.0 (2022), against an average of $2.8 million.
  • Year-over-year, Current Taxes tumbled 99.79% in 2022 and then soared 53.33% in 2023.
  • Atea Pharmaceuticals' Current Taxes stood at $2.6 million in 2021, then crashed by 96.15% to $99000.0 in 2022, then crashed by 76.77% to $23000.0 in 2023.
  • Per Business Quant, the three most recent readings for AVIR's Current Taxes are $23000.0 (Q2 2023), $178000.0 (Q1 2023), and $99000.0 (Q4 2022).